Article Information
PubMed
Published By
History
- Received January 11, 2008
- Revision received March 6, 2008
- Accepted March 26, 2008
- First published April 30, 2008.
- Version of record published April 30, 2008.
Copyright & Usage
Copyright © 2008 Society for Neuroscience 0270-6474/08/284795-12$15.00/0
Author Information
- Nicolas Mallet1,2,
- Alek Pogosyan2,
- Andrew Sharott3,
- Jozsef Csicsvari1,
- J. Paul Bolam1,
- Peter Brown2, and
- Peter J. Magill1
- 1Medical Research Council Anatomical Neuropharmacology Unit, University of Oxford, Oxford OX1 3TH, United Kingdom,
- 2Sobell Department of Motor Neuroscience and Movement Disorders, Institute of Neurology, London WC1N 3BG, United Kingdom, and
- 3Institute of Neurophysiology and Pathophysiology, University Hospital Hamburg-Eppendorf, University of Hamburg, 20246 Hamburg, Germany
- Correspondence should be addressed to Dr. Peter J. Magill, Medical Research Council Anatomical Neuropharmacology Unit, University of Oxford, Mansfield Road, Oxford OX1 3TH, UK. peter.magill{at}pharm.ox.ac.uk
Author contributions
Disclosures
- Received January 11, 2008.
- Revision received March 6, 2008.
- Accepted March 26, 2008.
-
This work was supported by the Medical Research Council (United Kingdom) and The Dana Foundation. A.S. was supported by the European Union Marie Curie Program. We are grateful to N. Maurice for advice on the use of receptor antagonists, to B. Averbeck for insightful comments on mutual information analysis, and to T. Klausberger, M. Brown, T. Senior, and K. Allen for their valuable input throughout. We also thank E. Norman, C. Francis, K. Whitworth, and B. Micklem ARPS for expert technical assistance.
- Correspondence should be addressed to Dr. Peter J. Magill, Medical Research Council Anatomical Neuropharmacology Unit, University of Oxford, Mansfield Road, Oxford OX1 3TH, UK. peter.magill{at}pharm.ox.ac.uk
Online Impact
